Reckitt Benckiser Group plc is a British multinational consumer goods company headquartered in Slough, England. It is a producer of health, hygiene and home products.
1999 Formed by the merger of the UK-based Reckitt and Colman and the Netherlands-based ‘’’Benckiser NV’’’.
In October 2005, Reckitt Benckiser agreed to purchase the over-the-counter drugs manufacturing business of Boots Group, ‘’’Boots Healthcare International’’’, for £1.9 billion. The three main brands acquired were Nurofen's analgesics, Strepsils sore throat lozenges, and Clearasil anti-acne treatments.
In January 2008, Reckitt Benckiser acquired Adams Respiratory Therapeutics, Inc., a pharmaceutical company, for $2.3 billion; one of the major brands acquired was Mucinex.
In July 2010, Reckitt Benckiser agreed to buy SSL International, the makers of Durex condoms and Scholl’s footcare products, in a £2.5 billion deal.
2014 Announced it was dropping its full name in favour of ‘‘’RB’’’. According to the chief executive, Rakesh Kapoor, the old name was "a bit of a mouthful" and the name change would make life easier.
2015 Operates in four divisions - Food, Health, Hygiene and Home. Total of 34,700 employees worldwide with 3,176 in the UK. Main brands are Durex, Gaviscon, Mucinex, Nurofen, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Finish, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Vanish, Woolite, French’s Mustard[1], Mycil and Vanish. It has operations in around 60 countries and its products are sold in almost 200 countries.
See Also
Sources of Information
- [2] Wikipedia